KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Hims & Hers Health (HIMS) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Hims & Hers Health (HIMS) over the last 6 years, with Q3 2025 value amounting to 2.65%.

  • Hims & Hers Health's EBITDA Margin fell 162700.0% to 2.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.08%, marking a year-over-year decrease of 21000.0%. This contributed to the annual value of 8.52% for FY2024, which is 112100.0% up from last year.
  • Latest data reveals that Hims & Hers Health reported EBITDA Margin of 2.65% as of Q3 2025, which was down 162700.0% from 7.98% recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's EBITDA Margin ranged from a high of 18.92% in Q3 2024 and a low of 98.38% during Q1 2021
  • Its 5-year average for EBITDA Margin is 9.73%, with a median of 3.51% in 2023.
  • As far as peak fluctuations go, Hims & Hers Health's EBITDA Margin tumbled by -781700bps in 2021, and later surged by 821500bps in 2022.
  • Quarter analysis of 5 years shows Hims & Hers Health's EBITDA Margin stood at 36.89% in 2021, then soared by 83bps to 6.41% in 2022, then surged by 108bps to 0.51% in 2023, then soared by 941bps to 5.29% in 2024, then crashed by -50bps to 2.65% in 2025.
  • Its last three reported values are 2.65% in Q3 2025, 7.98% for Q2 2025, and 8.47% during Q1 2025.